Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Reckitt Benckiser Group PLC Director's Dealing 2018

Jun 7, 2018

4872_dirs_2018-06-07_5550f288-fb06-4e61-bfed-bd21130f9359.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7052Q

Reckitt Benckiser Group PLC

07 June 2018

7 June 2018

RECKITT BENCKISER GROUP PLC

("RB" or the "Company")

DIRECTOR/PDMR SHAREHOLDING

Notification of transactions of Directors/Persons Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

On 7 June 2018, Rob de Groot, President Hygiene Home, a PDMR, exercised 214 share options granted on 6 November 2014 at an option price of £41.88 per share under the Reckitt Benckiser Group 2007 Global Stock Profit Plan and retained all of the resulting Shares.

Following this transaction, Mr de Groot's shareholding has increased to 362,834 Shares, representing 0.0514% of the Company's issued share capital. Treasury shares have not been taken into account when calculating this percentage.

The following notification is made in accordance with the requirements of the EU Market Abuse Regulation.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Rob de Groot

2

Reason for the notification

a)

Position/status

President Hygiene Home - a PDMR

b)

Initial notification/

Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Reckitt Benckiser Group plc

b)

LEI

5493003JFSMOJG48V108

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10p each in Reckitt Benckiser Group plc ("Shares")

GB00B24CGK77

b)

Nature of the transaction

Exercise of share options under the Reckitt Benckiser Group 2007 Global Stock Profit Plan and retention of the resulting Shares.

c)

Price(s) and volume(s)

Price(s) Volume(s)
GBP 41.88 214

d)

Aggregated information

-       Aggregated volume

-       Price

-

-

e)

Date of the transaction

2017-06-07

f)

Place of the transaction

Outside a trading venue

Contact:

Christine Logan

Deputy Company Secretary

Reckitt Benckiser Group plc

01753 217800

103-105 Bath Road, Slough SL1 3UH

Registered in England and Wales, No. 6270876 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

About RB:

RB is the global leading consumer health, hygiene and home company. Driven by a purpose of providing innovative solutions for healthier lives and happier homes, RB has operations in over 60 countries.  From the foundations of wellness and infant nutrition, to the fundamentals of a hygienic home, its global brands help people live healthier, happier lives.

RB has world leading Powerbrands which include household names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick.

RB's unique culture is at the heart of its success.  Its drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 employees worldwide. 

For more information visit www.rb.com 

*RB is the trading name of the Reckitt Benckiser group of companies

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHBUGDLDUGBGIR